Wave Life Sciences WVE Total debt

Total debt at other companies

Eli LillyLLY

$54.91B+37.6%

Sarepta Therapeutics, Inc.SRPT

$198.23M-7.6%

Ionis PharmaceuticalsIONS

$262.48M-67.0%

Madrigal Pharmaceuticals, Inc.MDGL

$377.85M+179%

ALN

Alnylam PharmaceuticalsALNY

$256.43M-5.2%

Beam TherapeuticsBEAM

$250.82M+58.6%

FAQ

What is Wave Life Sciences's total debt?

Wave Life Sciences (WVE) reported total debt of $43.59M in Q2 2026.

How has Wave Life Sciences's total debt changed year-over-year?

Wave Life Sciences's total debt increased by 100.8% year-over-year, from $21.71M to $43.59M.

What is the long-term trend for Wave Life Sciences's total debt?

Over 5 years (2020 to 2025), Wave Life Sciences's total debt has grown at a -9.5% compound annual growth rate (CAGR), from $29.31M to $17.77M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.